Public Profile

CoreRx, Inc.

CoreRx, Inc., a leading player in the pharmaceutical contract development and manufacturing industry, is headquartered in the United States. Founded in 2010, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, specialising in the development and production of complex drug formulations. With a focus on oral solid dosage forms, CoreRx offers a range of services, including formulation development, analytical testing, and commercial manufacturing. Their commitment to innovation and quality has positioned them as a preferred choice for clients seeking tailored solutions in drug development. CoreRx's notable achievements include a robust portfolio of successful product launches and a reputation for excellence in regulatory compliance, making them a key contributor to the advancement of healthcare solutions globally.

DitchCarbon Score

How does CoreRx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

CoreRx, Inc.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

CoreRx, Inc.'s reported carbon emissions

CoreRx, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their current carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing carbon emissions. As the industry increasingly prioritises sustainability, CoreRx, Inc. may need to establish clear climate goals and strategies to align with global efforts in combating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CoreRx, Inc.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. CoreRx, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CoreRx, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Societal CDMO, Inc.

US
Chemicals nec
Updated 30 days ago
DitchCarbon Score

Avara Pharmaceutical Services, Inc.

US
Chemicals nec
Updated 6 days ago

Bioserv Corporation

US
Health and social work services (85)
Updated 2 days ago

BioDuro-Sundia

US
Research and development services (73)
Updated 1 day ago

Patheon BV

US
Chemicals nec
Updated 30 days ago

Alcami

US
Fabricated metal products, except machinery and equipment (28)
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers